---
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/265394029.md"
description: "Elevance Health Inc. (ELV): It is expected that the inclusion of weight loss drugs in Medicare will not affect the performance outlook for 2026"
datetime: "2025-11-11T20:21:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265394029.md)
  - [en](https://longbridge.com/en/news/265394029.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265394029.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/265394029.md) | [English](https://longbridge.com/en/news/265394029.md)


# 

Elevance Health Inc. (ELV): It is expected that the inclusion of weight loss drugs in Medicare will not affect the performance outlook for 2026

### 相關股票

- [Elevance Health (ELV.US)](https://longbridge.com/zh-HK/quote/ELV.US.md)

## 相關資訊與研究

- [Advisory Resource Group Increases Stake in Elevance Health, Inc. $ELV](https://longbridge.com/zh-HK/news/271620755.md)
- [CF Industries Holdings, Inc. (NYSE:CF) Sees Significant Decrease in Short Interest](https://longbridge.com/zh-HK/news/281002395.md)
- [Summit Midstream Corporation Announces $42 Million Equity Issuance to Affiliate of Tailwater Capital | SMC Stock News](https://longbridge.com/zh-HK/news/281244975.md)
- [A2Z Announces Audited Full-Year 2025 Financial Results | AZ Stock News](https://longbridge.com/zh-HK/news/281374835.md)
- [ProPhase Labs Delays Annual 10-K Yearly Filing](https://longbridge.com/zh-HK/news/280853533.md)